AVX 0.00% 2.5¢ avexa limited

2010 provocative agents

  1. 701 Posts.
    MM&M's pipeline draws from the best drugs in development, profiling 15 agents with the highest approval rating and brightest commercial prospects. These are the prime near-term launch candidates. The report also provides updates on 202 products in a host of theraputic areas.

    ...

    OTHER KEY PRODUCTS IN THE PIPELINE

    APRICITABINE Avexa
    HIV Infection (Ph. III)


    Only other new HIV ART drugs mentioned
    Viciviroc Merck
    Rilpivirine Tibotec

    http://media.mmm-online.com/documents/12/pipeline2010_2759.pdf
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.